Abstract

Naoxintong capsule (NXT), a Chinese medicine, has performed excellent effects on the prevention and treatment against cardiovascular diseases. NXT is a fine powder mixture without any herb extraction, and there must be lots of ingredients hard to be absorbed. However, little is known about the correlation between the NXT’s cardioprotective effects and gut microbiota. Herein, we report the effect of NXT on the development of cardiovascular diseases and clarify the correlation between NXT’s cardioprotective effects and gut microbiota. In the current study, minipigs were selected and fed with high-fat diet and NXT daily for successive 8 months. During the process, up to 18 biomedical parameters were monthly determined to observe the dynamic changes after NXT treatment. At the end of experimental process, pathological examinations of heart, coronary artery, carotid artery, thoracic aorta, and abdominal aorta were conducted by HE staining and 16SrDNA sequencing, and analyzing of gut microbiota were conducted. Our results showed that NXT’s effects against cardiovascular diseases were through regulating blood lipid profiles, inhibiting vascular inflammation, enhancing antioxidant capacity, and alleviating myocardial injury, without damages on liver and kidney particularly. Concurrently, we also found that long-term administration of NXT increased the diversity of gut microbiota, influenced the microbiome structure and composition stably, and revered the increase of the ratio of the Firmicutes to Bacteroidetes (F/B ratio) in relative abundance. Specifically, our results revealed some key bacterium of Caproiciproducens (enhanced), Sutterella (enhanced), Erysipelotrichaceae (enhanced), and Romboutsia (decreased) that were closely involved in NXT’s effects. Taken together, our study demonstrates that NXT can inhibit the development of cardiovascular diseases by ameliorating high-fat diet–induced metabolic disorders and partly through improving gut microbiota.

Highlights

  • Atherosclerotic cardiovascular diseases are the leading cause of morbidity and mortality worldwide

  • Hematoxylin, and oil red O were purchased from Shanghai Aladdin Bio-Chem Technology Co., Ltd.; cholesterol was purchased from Guangzhou NOCIKAR Biotechnology Co., Ltd.; butter was purchased from Jieshou Yutu Edible Oil Co., Ltd.; peanut oil was purchased from Shandong Luhua Co., Ltd.; bile salt was purchased from China National Pharmaceutical Group Corporation Chemical Reagent Co., Ltd.; and basic feed were all provided by Dongguan Pearl Lab Animal Sci & Tech Co., Ltd

  • This study employed UFLC-Q-TOF-MS/MS detection to investigate the ingredients of Naoxintong capsule (NXT) for the quality control

Read more

Summary

Introduction

Atherosclerotic cardiovascular diseases are the leading cause of morbidity and mortality worldwide. Studies in vivo and in vitro have demonstrated that high-fat feeding could cause inflammation (Jakobsdottir et al, 2013), induce oxidative stress (Paula et al, 2016), generate endothelial dysfunctions (Knight et al, 2008), as well as exacerbate hepatic and renal injuries (Michal et al, 2004; Pinhal et al, 2013). Such high-fat diet–induced metabolic disorders are closely associated with the generation and development of atherosclerotic cardiovascular disease. Giving minipigs high-fat diet feeding can induce hyperlipidemia and atherosclerosis similar to that of humans (Shoumin et al, 2004; Miyoshi et al, 2010)

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.